Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.

News Releases

view all
    • News in Focus
        • Browse News Releases

        • All Public Company News
        • All Multimedia News
        • View All News Releases

        • Regulatory News

        • D/A/CH Regulatory News
        • UK Regulatory News
        • View All Regulatory News

    • Business & Money
        • Auto & Transportation

        • Aerospace & Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads & Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking & Road Transportation
        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film & Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers & Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalisation
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls & Research
        • Trade Show News
        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil & Gas Discoveries
        • Utilities
        • Water Utilities
        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defence
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation & Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking & Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers & Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines & Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics & Personal Care
        • Fashion
        • Food & Beverages
        • Furniture & Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewellery
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film & Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • View All Sports

        • Travel

        • Amusement Parks & Tourist Attractions
        • Gambling & Casinos
        • Hotels & Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Animal Welfare
        • Corporate Social Responsibility
        • Economic News, Trends & Analysis
        • Education
        • Environmental
        • European Government
        • Labour & Union
        • Natural Disasters
        • Not For Profit
        • Public Safety
        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Enquiries
    • Media Enquiries
    • Partnerships
    • Hamburger menu
    • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
    • Send a Release
      • Phone

      • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

      • ALL CONTACT INFO
      • Contact Us

        +44 (0)20 7454 5110
        from 8 AM - 5:30 PM GMT

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • 2 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • General Enquiries
      • Media Enquiries
      • Partnerships
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Regulatory News
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Visiongain Report Researches Growth Opportunities Within the $424bn Generic Drugs Market

      This image opens in the lightbox

      News provided by

      Visiongain

      21 Aug, 2019, 09:00 GMT

      Share this article

      Share this article


      Generic Drugs Market Forecast 2019-2029

      LONDON, Aug. 21, 2019 /PRNewswire/ -- Growth in Leading Regional and National Markets – North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America, US, Canada, Germany, France, UK, Italy, Spain, India, China, Australia, South Korea, Japan, South Africa, Saudi Arabia, U.A.E, Brazil, Argentina, Mexico, Teva, Novartis, Mylan, Pfizer, Abbott, Sun Pharma, Aspen, Fresenius Kabi, Sanofi, Dr. Reddy's Laboratories Limited, Apotex

      The generic drugs market is estimated to have reached $257.3bn in 2018 and is expected to grow at a CAGR of 8.8% in the first half of the forecast period. Asia-Pacific held 31% of the generic drugs market in 2018.

      How this report will benefit you
      Read on to discover how you can exploit the future business opportunities emerging in this sector.

      In this brand new 246-page report you will receive 66 tables and 84 figures– all unavailable elsewhere.

      The 246-page report provides clear detailed insight into the generic drugs market. Discover the key drivers and challenges affecting the market.

      By ordering and reading Visiongain's brand-new report today you stay better informed and ready to act.

      To request sample pages from this report please contact Sara Peerun at sara.peerun@visiongain.com or refer to our website: https://www.visiongain.com/report/generic-drugs-market-forecast-2019-2029/#download_sampe_div

      Report Scope

      • Generic Drugs Market forecasts from 2019-2029

      • Generic Drugs Market forecasts from 2019-2029 by Regional and National Market:
      • North America: U.S., Canada
      • Europe: Germany, France, UK, Italy, Spain, Rest of Europe
      • Asia-Pacific: Japan, China, Australia, South Korea, India, Rest of Asia-Pacific
      • Middle East & Africa: South Africa, Saudi Arabia, UAE, Rest of Middle east & Africa
      • Latin America: Brazil, Argentina, Mexico, Rest of Latin America

      • Profiles and generic drugs revenue forecasts from 2019-2029 of these selected leading companies:
      • Abbott
      • Apotex
      • Aspen
      • Dr. Reddy's Laboratories Limited
      • Fresenius Kabi
      • Mylan
      • Novartis
      • Pfizer
      • Sanofi
      • Sun Pharma
      • Teva

      • Qualitative analysis of the generic drugs market:
      • SWOT Analysis of the generic drugs market
      • Porter's Five Forces Analysis of the generic drugs market
      • Discussion on factors that drive and restrain the generic drugs market

      • Key Questions Answered by This Report:
      • How is the global market for generic drugs evolving?
      • What are the major factors driving and restraining the generic drugs market dynamics?
      • What were the market shares of the leading national markets in the global generic drugs market in 2018?
      • How will each of these national markets grow over the forecast period and how much revenue will these markets account for by 2029?
      • How will the market shares for each of the national markets develop from 2018 to 2029?
      • Which particular national markets will be the main drivers of growth in the global market for generics from 2018 to 2029?
      • How will political and regulatory factors influence the regional markets and submarkets?
      • What are the predictions for partnerships, consolidation for existing players and the potential prospects for new market entrants?
      • How will the industry sector evolve as legislations around patents and patent expiries change during the period between 2018 and 2029?

      To request a report overview of this report please contact Sara Peerun at sara.peerun@visiongain.com or refer to our website: https://www.visiongain.com/report/generic-drugs-market-forecast-2019-2029/

      Did you know that we also offer a report add-on service? Email sara.peerun@visiongain.com to discuss any customized research needs you may have.

      Companies covered in the report include:

      Abbott Laboratories
      AbbVie
      Able Labs
      Aché
      Actavis
      Agila Specialties
      Akron Pharmaceuticals
      Alkem Laboratories
      Allergan
      Amgen
      Anterios
      Arcolab
      ASKA Pharmaceuticals
      Aspen
      AstraZeneca
      Aurobindo
      Auspex Pharmaceuticals
      Baxter International
      Bayer
      Bedford Laboratories
      Bergamo
      Biocon
      Bioniche Pharma Holdings
      Caraco
      CFR Pharmaceuticals
      Cipla
      Claris
      Daiichi Sankyo
      Dalim BioTech
      Dr. Reddy's Laboratories
      Ebewe Pharma
      Eden Biopharm Group
      Elder Pharmaceuticals
      Eli Lilly Company
      Elyson Pharmaceuticals
      EMS Sigma Pharma
      Eon Labs
      Eurofarma Laboratories
      Farmacias Similares
      Filaxis
      Fougera Pharmaceuticals
      Fresenius Kabi
      Fuji Pharma
      Gavis Pharmaceuticals
      Grupo Sanborns
      Grupo Uriach
      GlaxoSmithKline (GSK)
      Hexal
      Hisun-Pfizer Pharmaceuticals
      Hospira Healthcare India Private Limited
      Ilsung Pharmaceuticals
      Imperial Credit Private Limited
      InnoPharma
      Itero Biopharmaceuticals
      Janssen Pharmaceuticals
      Johnson & Johnson
      King Pharmaceuticals
      Kmart
      KMS Pharmaceutical
      Kowa Pharmaceuticals
      Labesfal
      Laboratorio Sanderso
      Laboratorios Best
      Lek
      Lundbeck
      Lupin Pharmaceuticals
      Mayne Pharma
      Meda AB
      Medley
      Merck KGaA's
      Momenta
      MSD
      Mylan
      Natco
      Nexus Pharmaceuticals
      Nichi-Iko
      Nippon Chemiphar
      Novartis (Sandoz)
      Novo Nordisk
      Orchid Chemicals & Pharmaceuticals
      Oriel Therapeutics
      Patriot Pharma
      Pfizer
      Pharmacia
      Piramal
      PT Ethica Industry Farmasi
      PT Soho Global Health
      Ranbaxy
      Ratiopharm
      Ribbon
      Rimsa
      Roche
      Sabex
      Sandoz
      Sanofi
      Sawai Pharmaceuticals
      Servier
      Sigma Pharmaceuticals
      Solvay Pharmaceuticals
      St. Jude Medical
      STADA Arzneimittel
      Strides Arcolab
      Sun Pharma
      Synthélabo
      Taisho Pharmaceutical
      Taiyo Pharmaceuticals
      Takeda Pharmaceutical Company Limited
      Target
      Teuto Brasileiro
      Teva
      Torrent Pharmaceuticals
      Towa
      Walmart
      Warner Chilcott
      Watson Pharmaceuticals
      Werner – Lambert
      Wockhardt
      Wyeth
      Zentiva
      Zhejiang Hisun Pharmaceutical
      Zydus Cadila

      List of Organisations Mentioned in the Report
      Agência Nacional de Vigilância Sanitária
      American Pharmaceutical Association
      Blue Cross Blue Shield Association
      British Generic Manufacturers Association
      Caisse Nationale de l'Assurance Maladie
      Center for Drug Evaluation and Research
      Centers for Medicare and Medicaid
      Competition Commission of India
      European Generic Medicines Association
      European Medicines Agency
      Italian Generics Association, Assogenerici
      Medical Technology Association of Australia
      Ministry of Health, Labour and Welfare
      National Health Service
      National Health Surveillance Agency
      Pharmaceuticals and Medical Devices Agency
      Servicio Sanitario Nazionale
      US Federal Trade Comission
      US Generic Pharmaceutical Association

      To see a report overview please e-mail Sara Peerun on sara.peerun@visiongain.com

      Related reports:

      Pharma Leader Series: Top Generic Drug Producers Market Forecast 2019-2029

      Global Anti-Obesity Drugs Market Forecast 2018-2028

      Global Antidepressant and Anti-Anxiety Drugs Market 2019-2029

      Global Antibacterial Drugs Market 2019-2029

      Indian Pharmaceutical Market Forecast 2019-2029

      Logo: https://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg

      Modal title

      Contact PR Newswire

      • +44 (0)20 7454 5110
        from 8 AM - 5:30 PM GMT
      • General Enquiries
      • Media Enquiries
      • Partnerships

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United States
      • Vietnam

      My Services

      • All News Releases
      • PR Newswire Amplify™
      • Resources
      • Journalists
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via Privacy@cision.com 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Customer Portal
      • Resources
      • Journalists
      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookie Settings
      Copyright © 2026 PR Newswire Europe Limited. All Rights Reserved. A Cision company.